Compare $ATOS vs $BYSI | Chartloom

Compare

$ATOS vs $BYSI

Atossa Therapeutics Inc · Beyondspring Inc

ATOS

Atossa Therapeutics Inc

BYSI

Beyondspring Inc

Compare $ATOS vs $BYSI

Comparing Atossa Therapeutics Inc and Beyondspring Inc

ATOSAtossa Therapeutics Inc

BYSIBeyondspring Inc

ATOSAtossa Therapeutics Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.2%

52W performance

-85.3%

FCF yield

-147.1%

BYSIBeyondspring Inc

Market cap

$25M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.4%

52W performance

-66.2%

FCF yield

-67.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATOS

BYSI

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

BYSI

Beyondspring Inc

Market Cap

ATOS$24M

BYSI$25M

Enterprise Value

ATOS$-2M

BYSI$22M

Price

ATOS$2.44

BYSI$0.61

P/E Ratio

ATOSN/A

BYSIN/A

P/S Ratio

ATOS145.95x

BYSI23.96x

EV/Sales

ATOS-17.14x

BYSI21.97x

EV/EBITDA

ATOS0.00x

BYSI0.00x

P/B Ratio

ATOS0.87x

BYSI3.99x

P/FCF Ratio

ATOSN/A

BYSIN/A

EV/FCF

ATOS0.05x

BYSI-1.33x

PEG Ratio

ATOSN/A

BYSIN/A

Forward P/E (NTM)

ATOSN/A

BYSIN/A

Forward P/S (NTM)

ATOSN/A

BYSIN/A

Revenue (TTM)

ATOS$0

BYSI$0

Revenue Growth (YoY)

ATOSN/A

BYSIN/A

Forward Rev Growth

ATOS184.1%

BYSI0.0%

Gross Margin (TTM)

ATOS62.5%

BYSI0.0%

Operating Margin (TTM)

ATOS0.0%

BYSI0.0%

EBITDA Margin (TTM)

ATOS0.0%

BYSI0.0%

Net Margin (TTM)

ATOS0.0%

BYSI0.0%

FCF Margin (TTM)

ATOSN/A

BYSIN/A

Net Income (TTM)

ATOS$-38M

BYSI$-7M

FCF (TTM)

ATOS$-36M

BYSI$-17M

EPS (TTM)

ATOS-$4.23

BYSI-$0.16

ROE (TTM)

ATOS-10299.0%

BYSI-13313.0%

ROA (TTM)

ATOS-8578.0%

BYSI-3024.0%

ROIC (TTM)

ATOS-10299.0%

BYSI-12817.0%

Cash

ATOS$26M

BYSI$3M

Debt

ATOS$0

BYSI$0

Net Cash/Debt

ATOS$26M

BYSI$3M

Current Ratio (TTM)

ATOS5.69x

BYSI0.70x

Quick Ratio (TTM)

ATOS4.81x

BYSI0.66x

Debt/Equity (TTM)

ATOS0.00x

BYSI0.06x

Debt/Assets (TTM)

ATOS0.0%

BYSI0.0%

Interest Coverage (TTM)

ATOSN/A

BYSIN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

BYSI0.00x

Beta

ATOS1.39

BYSI-0.26

52W Performance

ATOS-85.3%

BYSI-66.2%

YTD Performance

ATOS-74.2%

BYSI-62.4%

% from 52W High

ATOS-87.4%

BYSI-75.2%

% from 52W Low

ATOS43.5%

BYSI7.1%

Asset Turnover (TTM)

ATOS0.01x

BYSI0.02x

FCF Yield (TTM)

ATOS-147.1%

BYSI-67.2%

Earnings Yield (TTM)

ATOS-155.0%

BYSI-26.8%

Dividend Yield (TTM)

ATOSN/A

BYSIN/A

Rule of 40

ATOS0.0

BYSI0.0

EV/GP/RG

ATOSN/A

BYSIN/A

Ticker research

View ATOS research View BYSI research

Metric	ATOS Atossa Therapeutics Inc	BYSI Beyondspring Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$-2M	$22M
Price	$2.44	$0.61
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	23.96x
EV/Sales	-17.14x	21.97x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	184.1%	0.0%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-7M
FCF (TTM)	$-36M	$-17M
EPS (TTM)	-$4.23	-$0.16
ROE (TTM)	-10299.0%	-13313.0%
ROA (TTM)	-8578.0%	-3024.0%
ROIC (TTM)	-10299.0%	-12817.0%
Financial Health
Cash	$26M	$3M
Debt	$0	$0
Net Cash/Debt	$26M	$3M
Current Ratio (TTM)	5.69x	0.70x
Quick Ratio (TTM)	4.81x	0.66x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	-0.26
52W Performance	-85.3%	-66.2%
YTD Performance	-74.2%	-62.4%
% from 52W High	-87.4%	-75.2%
% from 52W Low	43.5%	7.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-147.1%	-67.2%
Earnings Yield (TTM)	-155.0%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View BYSI research

Valuation

P/S Ratio

BYSI

23.96x

ATOS

145.95x

EV/FCF

BYSI

-1.33x

ATOS

0.05x

Growth & revenue

Forward Revenue Growth

ATOS

184.1%

BYSI

0.0%

Profitability & performance

Gross Margin

ATOS

62.5%

BYSI

0.0%

ROE

ATOS

-10299.0%

BYSI

-13313.0%

FCF Yield %

BYSI

-67.2%

ATOS

-147.1%

52-Week Performance

BYSI

-66.2%

ATOS

-85.3%

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

BYSI

Beyondspring Inc

Market Cap

ATOS$24M

BYSI$25M

Enterprise Value

ATOS$-2M

BYSI$22M

Price

ATOS$2.44

BYSI$0.61

P/E Ratio

ATOSN/A

BYSIN/A

P/S Ratio

ATOS145.95x

BYSI23.96x

EV/Sales

ATOS-17.14x

BYSI21.97x

EV/EBITDA

ATOS0.00x

BYSI0.00x

P/B Ratio

ATOS0.87x

BYSI3.99x

P/FCF Ratio

ATOSN/A

BYSIN/A

EV/FCF

ATOS0.05x

BYSI-1.33x

PEG Ratio

ATOSN/A

BYSIN/A

Forward P/E (NTM)

ATOSN/A

BYSIN/A

Forward P/S (NTM)

ATOSN/A

BYSIN/A

Revenue (TTM)

ATOS$0

BYSI$0

Revenue Growth (YoY)

ATOSN/A

BYSIN/A

Forward Rev Growth

ATOS184.1%

BYSI0.0%

Gross Margin (TTM)

ATOS62.5%

BYSI0.0%

Operating Margin (TTM)

ATOS0.0%

BYSI0.0%

EBITDA Margin (TTM)

ATOS0.0%

BYSI0.0%

Net Margin (TTM)

ATOS0.0%

BYSI0.0%

FCF Margin (TTM)

ATOSN/A

BYSIN/A

Net Income (TTM)

ATOS$-38M

BYSI$-7M

FCF (TTM)

ATOS$-36M

BYSI$-17M

EPS (TTM)

ATOS-$4.23

BYSI-$0.16

ROE (TTM)

ATOS-10299.0%

BYSI-13313.0%

ROA (TTM)

ATOS-8578.0%

BYSI-3024.0%

ROIC (TTM)

ATOS-10299.0%

BYSI-12817.0%

Cash

ATOS$26M

BYSI$3M

Debt

ATOS$0

BYSI$0

Net Cash/Debt

ATOS$26M

BYSI$3M

Current Ratio (TTM)

ATOS5.69x

BYSI0.70x

Quick Ratio (TTM)

ATOS4.81x

BYSI0.66x

Debt/Equity (TTM)

ATOS0.00x

BYSI0.06x

Debt/Assets (TTM)

ATOS0.0%

BYSI0.0%

Interest Coverage (TTM)

ATOSN/A

BYSIN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

BYSI0.00x

Beta

ATOS1.39

BYSI-0.26

52W Performance

ATOS-85.3%

BYSI-66.2%

YTD Performance

ATOS-74.2%

BYSI-62.4%

% from 52W High

ATOS-87.4%

BYSI-75.2%

% from 52W Low

ATOS43.5%

BYSI7.1%

Asset Turnover (TTM)

ATOS0.01x

BYSI0.02x

FCF Yield (TTM)

ATOS-147.1%

BYSI-67.2%

Earnings Yield (TTM)

ATOS-155.0%

BYSI-26.8%

Dividend Yield (TTM)

ATOSN/A

BYSIN/A

Rule of 40

ATOS0.0

BYSI0.0

EV/GP/RG

ATOSN/A

BYSIN/A

Ticker research

View ATOS research View BYSI research

Metric	ATOS Atossa Therapeutics Inc	BYSI Beyondspring Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$-2M	$22M
Price	$2.44	$0.61
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	23.96x
EV/Sales	-17.14x	21.97x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	184.1%	0.0%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-7M
FCF (TTM)	$-36M	$-17M
EPS (TTM)	-$4.23	-$0.16
ROE (TTM)	-10299.0%	-13313.0%
ROA (TTM)	-8578.0%	-3024.0%
ROIC (TTM)	-10299.0%	-12817.0%
Financial Health
Cash	$26M	$3M
Debt	$0	$0
Net Cash/Debt	$26M	$3M
Current Ratio (TTM)	5.69x	0.70x
Quick Ratio (TTM)	4.81x	0.66x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	-0.26
52W Performance	-85.3%	-66.2%
YTD Performance	-74.2%	-62.4%
% from 52W High	-87.4%	-75.2%
% from 52W Low	43.5%	7.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-147.1%	-67.2%
Earnings Yield (TTM)	-155.0%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View BYSI research